Strong Revenue and Earnings Growth
Siemens Healthineers reported nearly 6% revenue growth in Q1 2025, within the full-year guidance range. Adjusted earnings per share increased due to top-line growth and margin expansion.
Excellent Order Intake
The company achieved an equipment book-to-bill ratio of 1.21, driven by strong order intake across all businesses and markets, particularly in Imaging and Varian segments.
Varian and Advanced Therapies Performance
Varian reported over 17% margin in Q1, continuing its strong growth. Advanced Therapies also showed good growth and margin stability despite some quarterly volatility.
Diagnostics Segment Transformation
The Diagnostics segment achieved a margin of 8% in Q1, showing significant progress in its transformation efforts.
Record Free Cash Flow
Free cash flow more than tripled year-over-year, reaching €810 million, driven by improved operating working capital.
Photon-Counting CT and Innovation Leadership
Siemens Healthineers expanded its photon-counting CT fleet and demonstrated innovation leadership at the RSNA conference, further solidifying its market position.